Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of astaxanthin in preparing medicine for preventing embryotoxicity caused by organophosphorus pesticide

A technology of organophosphorus pesticides and embryotoxicity, applied in the direction of organic active ingredients, drug combinations, anti-toxins, etc., to achieve the effects of inhibiting weight gain, prolonging life, and good dose dependence

Inactive Publication Date: 2013-04-17
XINXIANG MEDICAL UNIV
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although most people have paid attention to the prevention of acute poisoning of organophosphorus pesticides, the impact of long-term, low-dose, and chronic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of astaxanthin in preparing medicine for preventing embryotoxicity caused by organophosphorus pesticide
  • Application of astaxanthin in preparing medicine for preventing embryotoxicity caused by organophosphorus pesticide
  • Application of astaxanthin in preparing medicine for preventing embryotoxicity caused by organophosphorus pesticide

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine novel application of astaxanthin, namely the effect of preventing and treating embryotoxicity caused by organophosphorus pesticide and the effects of inhibiting reduction of embryo live rate, rising of embryo still birth rate or embryo absorption rate and the reduction of placenta weight, which are caused by the organophosphorus pesticide. A pharmacological test verifies that the astaxanthin can effectively inhibit pregnant rat live embryo quantity, the reduction of the embryo live rate, the rising of the still birth rate or the embryo absorption rate, and the reduction of the weight, the body length, the tail length and the placenta weight of live fetal rats, which are caused by the organophosphorus pesticide (moncrotophos and phoxim); and the astaxanthin can inhibit the embryotoxicity caused by the organophosphorus pesticide and has the effective dosage dependence. The astaxanthin has the good inhibition effect on the embryotoxicity caused by the organophosphorus pesticide, can be used for preparing a medicine of the embryotoxicity caused by the organophosphorus pesticide, and can also be used for preparing a medicine for preventing and treating diseases induced by the embryotoxicity caused by the organophosphorus pesticide.

Description

technical field [0001] The invention relates to the application of astaxanthin, in particular to the application of astaxanthin in the preparation of medicines for preventing and treating embryotoxic diseases caused by organophosphorus pesticides. Background technique [0002] Organophosphorus pesticides (OPs) are a class of high-efficiency and low-residue pesticides, which have become the broadest-spectrum pesticides used in China today. The use of organophosphorus pesticides has made great contributions to the increase of production and harvest in agriculture, forestry, and fishery. However, with the widespread use of organophosphorus pesticides, their residues in vegetables and fruits are also more common. Although most people have paid attention to the prevention of acute poisoning of organophosphorus pesticides, the impact of long-term, low-dose, and chronic exposure of organophosphorus pesticides on human health, especially the impact of pregnant women on offspring, ha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/122A61P39/02A61P15/06A61P15/00
Inventor 闫建国周亚莉付升旗陶晶任铭新
Owner XINXIANG MEDICAL UNIV
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More